Alpha Thalassemia Diagnosis and Management
Diagnostic Approach
- Screening of parents with mean corpuscular volume (MCV) is recommended, as values <80 fL suggest possible alpha thalassemia carrier status, according to the American College of Obstetricians and Gynecologists 1
Clinical Implications and Management
- In severe cases like Hemoglobin Bart's hydrops fetalis (four-gene deletion), prenatal diagnosis is critical as it typically leads to fetal demise, as stated by the American College of Obstetricians and Gynecologists 2, 1
- Alpha thalassemia is the most common cause of non-immune hydrops fetalis in Southeast Asian populations, accounting for 28-55% of cases, as reported by the American College of Obstetricians and Gynecologists 1
Common Pitfalls in Diagnosis
- Failure to consider ethnicity in the diagnostic approach (alpha thalassemia is more common in Southeast Asian, Mediterranean, and Middle Eastern populations) can lead to missed diagnoses, according to the American College of Obstetricians and Gynecologists 1
Genetic Testing for Alpha Thalassemia
Pre-Test Genetic Counseling and Family Testing Strategy
- A cascade testing approach is recommended by the American Society of Transplantation, where the affected family member is tested first to identify the specific genetic mutation, followed by targeted testing of at-risk family members 3
- Pre-test counseling should include discussion of the benefits of testing, such as diagnosis confirmation and reproductive planning, as well as potential implications for family members and limitations of testing, according to the American Journal of Transplantation 3
Alpha Thalassemia Diagnostic Approach and Management
Diagnostic Workup
- The American College of Obstetricians and Gynecologists recommends checking parental mean corpuscular volume (MCV) values, with those less than 80 fL indicating possible alpha thalassemia carrier status, and considering ethnicity as alpha thalassemia is most prevalent in Southeast Asian, Mediterranean, Middle Eastern, and African populations 4
- DNA testing for deletions or point mutations is the definitive diagnostic test to identify the specific genetic defect, according to the American College of Medical Genetics 4
- Prenatal diagnosis using amniocentesis or fetal blood sampling is recommended when both parents are carriers to detect severe forms like Hb Bart's hydrops fetalis, which is typically fatal 4
- Middle cerebral artery Doppler is used to assess for fetal anemia in cases of suspected hydrops fetalis, as recommended by the American Institute of Ultrasound in Medicine 4
Treatment by Clinical Severity
- The American College of Obstetricians and Gynecologists states that Hb Bart's hydrops fetalis results in severe intrauterine hypoxia and non-immune hydrops fetalis presenting in late second or early third trimester, and intrauterine transfusion is considered investigational and not generally recommended outside research settings 4
Bloodwork Monitoring for Alpha Thalassemia
Monitoring Based on Alpha Thalassemia Severity
Hemoglobin H Disease (Alpha Thalassemia Intermedia, 3 gene deletions)
- The American Society of Hematology recommends monitoring with CBC every 3-6 months to assess for worsening hemolytic anemia and determine transfusion needs in patients with Hemoglobin H Disease 5